G.R. No. 237938 - Ferdo vs. Commission on Audit

Case Summary (G.R. No. 237938)

Factual Background

Marlo A. Deoferio was employed by Intel Technology Philippines, Inc. beginning February 1, 1996 and was assigned to the United States in July 2001. He was repatriated on January 27, 2002 after confinement for major depression with psychosis. Intel continued to finance his medical and psychiatric treatment. Various medical practitioners, including Dr. Elizabeth Rondain, Dr. Norieta Balderrama, Dr. Cynthia Leynes, and Dr. Paul Lee, treated and assessed Mr. Deoferio. Dr. Lee, a consultant psychiatrist, concluded in a report dated January 17, 2006 that the employee suffered from schizophrenia and that his psychotic symptoms were not curable within six months and would negatively affect his work and social relationships. Intel issued a notice of termination on March 10, 2006.

Trial Court Proceedings

Marlo A. Deoferio filed a complaint for illegal dismissal with monetary claims contending that he did not suffer from mental illness, that he performed satisfactorily, and that Intel violated his statutory right to procedural due process by summarily terminating him. The respondents defended the dismissal on the basis of Dr. Lee’s certification and cited prior incidents and absences allegedly demonstrating a risk to co-employees and impaired work performance. The Labor Arbiter, in a decision dated March 6, 2008, found that the termination was valid under Article 284 of the Labor Code and that the twin-notice requirement did not apply to disease-related dismissals. The Arbiter denied Deoferio’s monetary claims. The NLRC affirmed the Labor Arbiter’s decision and denied reconsideration.

Court of Appeals Ruling

The Court of Appeals upheld the findings of the Labor Arbiter and the NLRC in CA-G.R. SP No. 115708. The CA accepted Dr. Lee’s psychiatric report as substantial proof that the petitioner suffered from schizophrenia that was not curable within six months and that continued employment would be prejudicial to his health and to the health of co-employees. The CA also held that the IRR required only certification by a competent public health authority for disease-based termination and that Intel validly offset separation pay by the petitioner’s matured car loan.

The Parties’ Contentions Before the Supreme Court

Marlo A. Deoferio argued that the finding of schizophrenia was undermined by his subsequent employment with other corporations that offered higher compensation and that the twin-notice requirement must apply to terminations due to disease. He sought salary differential, backwages, separation pay, moral and exemplary damages, and attorney’s fees. Intel Technology Philippines, Inc. and Mike Wentling replied that the petition presented factual questions not proper on certiorari, that Dr. Lee’s certification controlled the inquiry into non-curability within six months, and that the salary differential claim was barred by prescription under Article 291 of the Labor Code. They also relied on the International Assignment Relocation Agreement to contend that the United States assignment was temporary and not a guaranteed salary basis.

Issues Presented

The Supreme Court framed the issues as: (1) whether the petitioner suffered from schizophrenia and whether continued employment was prejudicial to his health and that of co-employees; (2) whether the twin-notice requirement applies to terminations under Article 284 of the Labor Code, including whether nominal damages and solidary liability should follow for procedural violations; and (3) whether the petitioner was entitled to salary differential, backwages, separation pay, moral and exemplary damages, and attorneys fees.

Ruling

The Court granted the petition in part and denied it in part. It held that Intel Technology Philippines, Inc. had an authorized cause to terminate Marlo A. Deoferio under Article 284 of the Labor Code because Dr. Lee’s psychiatric report constituted substantial evidence that the petitioner suffered from schizophrenia not curable within six months and that continued employment would be prejudicial to his health. The Court reversed the Court of Appeals and NLRC only insofar as they erred in holding that the twin-notice requirement did not apply; the Court found a procedural due process violation and awarded nominal damages. The petition was denied in all other respects.

Legal Reasoning on Substantive Cause

The Court reiterated that termination for disease under Article 284 of the Labor Code requires proof of three elements: that the employee suffers from any disease; that continued employment is prohibited by law or prejudicial to his health and the health of co-employees; and that a competent public health authority certifies that the disease is not curable within six months even with proper treatment. The Court construed the phrase “prejudicial to his health as well as to the health of his co-employees” liberally to mean prejudicial to either the employee’s health or the health of co-employees, and it applied the provision to non-contagious conditions. The Court found that Dr. Lee’s report satisfied the substantive requirement of a competent public health authority’s certification and that the record of unusual conduct supported the conclusion that continued employment would be prejudicial.

Legal Reasoning on Procedural Due Process

The Court held that the IRR’s mandate of procedural due process in dismissals applies to disease-based terminations because Section 2, Rule 1, Book VI of the IRR requires procedural due process in all cases of dismissals. The Court recognized the line of jurisprudence in Sy v. Court of Appeals and Manly Express, Inc. v. Payong, Jr. which required the employer to furnish two written notices in terminations: first, a notice apprising the employee of the ground for dismissal and offering opportunity to answer; and second, a written notice of termination after consideration of the employee’s explanation. The Court found that the NLRC’s ruling to the contrary was arbitrary and a jurisdictional error.

Damages, Offsets, and Liability of Corporate Officer

The Court awarded Marlo A. Deoferio nominal damages of P30,000.00 for the statutory procedural due process violation. In fixing the amount, the Court applied its precedent in Jaka Food Processing Corp. v. Pacot and considered factors such as Intel’s financial and medical assistance, the employer’s flexibility in allowing leaves, the offset of separation pay by the matured car loan under Article 1278 and Article 1706 of the Civil Code and Article 113(c) of the Labor Code, and Intel’s bona fide attempt to comply with Article 284 and the IRR. The Court held that Mik

Case Syllabus (G.R. No. 237938)

Parties and Procedural Posture

Marlo A. Deoferio filed a complaint for illegal dismissal with money claims against Intel Technology Philippines, Inc. and Mike Wentling following his March 10, 2006 notice of termination.
The Labor Arbiter rendered a decision on March 6, 2008 finding the dismissal valid and denying Deoferio's monetary claims.
The National Labor Relations Commission affirmed the Labor Arbiter's decision and denied Deoferio's motion for reconsideration.
Deoferio sought certiorari relief before the Court of Appeals under Rule 65, which denied relief on February 24, 2012, and the denial of reconsideration was resolved on August 2, 2012.
Marlo A. Deoferio elevated the case to the Supreme Court by petition for review on certiorari under Rule 45.

Key Factual Allegations

Deoferio was first employed by Intel on February 1, 1996 and was assigned to the United States in July 2001 with an agreed two-year period and US$3,000.00 monthly salary.
Deoferio was repatriated to the Philippines on January 27, 2002 after confinement at Providence St. Vincent Medical Center for major depression with psychosis.
Multiple medical practitioners, including Dr. Elizabeth Rondain, Dr. Norieta Balderrama, Dr. Cynthia Leynes, and Dr. Paul Lee, examined Deoferio, and Dr. Lee's reports concluded that he suffered from schizophrenia and that his psychotic symptoms were not curable within six months.
Intel financed Deoferio's medical and psychiatric treatment and allowed lengthy leaves of absence, including administrative leave with pay from January 2005 until December 2005.
Intel relied on Dr. Lee's certification to issue the March 10, 2006 notice of termination and asserted that Deoferio's acts at work and repeated absences posed a threat to co-employees' health.
Deoferio denied having any mental illness, claimed satisfactory job performance, and sought salary differential, backwages, separation pay, moral and exemplary damages, and attorneys' fees.

Issues Presented

Whether Deoferio was suffering from schizophrenia and whether his continued employment was prejudicial to his health and to the health of his co-employees.
Whether the twin-notice requirement applies to terminations due to disease under Article 284 of the Labor Code.
Whether Deoferio was entitled to nominal damages for a violation of his right to statutory procedural due process and whether the respondents were solidarily liable for nominal damages.
Whether Deoferio was entitled to salary differential, backwages, separation pay, moral and exemplary damages, and attorneys' fees.

Statutory Framework

Article 284 of the Labor Code (now renumbered as Article 298 of the Labor Code) provides termination for disease as an authorized cause for dismissal and mandates separation pay.
The implementing rules and regulations, Book VI, Rule 1, Section 8 of the Labor Code IRR, require that due process be observed in all dismissals and prescribe the standards for notice and hearings.
Article 291 of the Labor Code (now renumbered as Article 305 of the Labor Code) prescribes a three-year prescriptive period for money claims arising from employer-employee relations.
Civil Code provisions on compensation and withholding of wages cited include Article 1278, Article 1706, and Article 113(c) in relation to set-off and deduction principles.

Lower Courts' Findings

The Labor Arbiter found that Deoferio was validly dismissed because Dr. Lee's certification showed non-curable schizophrenia and that continued employment posed a threat to co-employees' health.
The Labor Arbiter concluded that the twin-notice requirement did not apply to dismissals due to disease and dismissed Deoferio's monetary claims as unmeritorious.
The NLRC affirmed the Labor Arbiter's decision and de